Cancer: 30 preventable risk factors account for 40% of cases

Evan Walker
Evan Walker TheMediTary.Com |
crowd seen from aboveShare on Pinterest
Almost 40% of cancer cases globally are preventable, according to a new landmark study. Image credit: Alexander Spatari/Getty Images
  • A new landmark analysis from the World Health Organization (WHO) and its subdivision, the International Agency for Research on Cancer (IARC), emphasizes just how many cancer cases globally could be prevented through lifestyle choices.
  • According to the analysis, up to four in 10 new cases of cancer globally are preventable.
  • One striking finding also suggests that there are significantly more cancer cases affecting the male versus the female population.
  • The analysis outlines 30 modifiable risk factors, including, for the first time, nine types of infections.

Ahead of World Cancer Day 2026, on February 4, the World Health Organization (WHO)’s subdivision, the International Agency for Research on Cancer (IARC) has released a landmark analysis assessing preventable cancer cases at a global level.

The analysis, which appears in Nature Medicine, looks at as many as 30 risk factors for different types of cancer, all of which could be prevented through lifestyle choices and careful health management.

According to the authors, an estimated 37%, or about four in every 10 new cancer cases in 2022, the last year for which full data was available, were likely caused by preventable factors.

This amounts to approximately 7.1 million cases globally.

The IARC considered a wide array of modifiable risk factors, including smoking (tobacco use), alcohol consumption, body mass index (BMI), a sedentary lifestyle, air pollution, and exposure to ultraviolet radiation.

Additionally, for the first time ever, the researchers accounted for the impact of nine viral, bacterial, and parasitic infections linked to different forms of cancer. The infectious agents the team looked at were:

  1. Helicobacter pylori, a bacterium that infects the stomach and can cause stomach and sometimes colorectal cancer
  2. High-risk human papillomavirus (HPV), which includes types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59, and is linked to cervical cancer
  3. The hepatitis B virus (HBV) and the hepatitis C virus (HCV), both of which affect the liver and are linked to liver cancer
  4. The Epstein–Barr virus, which is linked to nasopharyngeal carcinoma, Burkitt lymphoma (a form of non-Hodgkin lymphoma), and Hodgkin’s lymphoma
  5. The human herpes virus type (HHV-8), which can cause Kaposi sarcoma
  6. Schistosoma haematobium, which causes a parasitic infection linked to bladder cancer
  7. human T‑cell lymphotropic virus, which can be a risk factor for leukemia
  8. Opisthorchis viverrini, which can cause a parasitic infection sometimes linked to cancer of the bile ducts
  9. and Clonorchis sinensis, a foodborne pathogen likewise linked to bile duct cancer.

While all of these infections are preventable through vaccination and screening, access to these measures is limited in certain regions of the world.

“Infections account for a particularly large share of cancers in sub-Saharan Africa and parts of Asia, where high prevalence of HPV, H. pylori, HBV, HCV and other agents is sustained by limited access to vaccines, testing and screening, safe water and sanitation, and timely treatment,” study author Isabelle Soerjomataram, MD, PhD, Deputy Head of the Cancer Surveillance Unit (CSU) at the IARC, explained to MNT.

“The study highlights several effective [prevention] strategies [for cancers caused by infections]: scaling up HPV vaccination, implementing and maintaining HBV birth-dose vaccination and broader HBV/HCV control, and test‑and‑treat or eradication programmes for H. pylori in high risk settings,” added Soerjomataram.

One of the most striking findings of the analysis was that, overall, there were significantly higher rates of preventable cancers among men than among women.

More than 45% (or 4.3 million) of new cancer cases in men, globally, were linked to preventable causes, while modifiable risk factors accounted for approximately 30% (2.7 million) of new cases in women.

As to the causes, smoking was the highest risk factor for men, accounting for a little over 23% of all new cancer cases.

In women, infections were the most notable culprit, accounting for 11.5% of all new cancer cases.

“Overall, about 45.4% of cancers in men versus 29.7% in women are attributable to the included risk factors, with especially high fractions in men in East Asia and parts of Europe,” Soerjomataram told us.

The study author explained that:

“Men tend to have higher exposure to several major risks — notably tobacco smoking, alcohol, and some occupational carcinogens — and these factors drive high burdens of lung, stomach, liver, and colorectal cancers, whereas women’s risk profile is more diversified and variable between higher and lower income regions.”

However, she cautioned that “some determinants that are particularly relevant for women, including several reproductive and hormonal factors, are not captured in this analysis, so the proportion of cancers attributable to modifiable factors in women is likely underestimated.”

“Importantly, the findings reinforce the need for gender-responsive cancer prevention and research, ensuring that policies and interventions are designed and implemented in ways that address the distinct risk profiles and social contexts of women and men,” Soerjomataram added.

Advising on prevention strategies for cancer at the individual level, Bilchik said everyone can take concrete action right now to reduce their risk.

“Cessation of smoking, Healthy lifestyle and obesity reduction, exercise, awareness of environmental carcinogens such as asbestos, a Healthy diet reducing processed food, reduction of alcohol intake are important in cancer in reduction in both men and women,” he advised.

Speaking of policy interventions, Bilchik championed improved availability of HPV vaccination at the global level, which is a proven intervention for the prevention of cervical cancer.

He also argued in favor of “routine testing and subsequent treatment of H. pylori,” a crucial risk factor for stomach cancer worldwide.

“Cancer can be prevented, and modifiable risk factors are responsible for a large share of the global cancer burden,” Soerjomataram reiterated.

“Tobacco and infection control (notably human papillomavirus, hepatitis B and C virus), reduction of alcohol consumption, and policies addressing excess body weight, physical inactivity, and air pollution should be top priorities, tailored to local patterns,” she emphasized.

Finally, she concluded, “countries should implement, monitor and evaluate comprehensive policy packages […], supported by improved surveillance system for cancer and its risk factors.”

Share this Article